Skip to main content
. Author manuscript; available in PMC: 2016 May 20.
Published in final edited form as: Bioconjug Chem. 2015 Apr 30;26(5):807–811. doi: 10.1021/acs.bioconjchem.5b00111

Figure 1.

Figure 1

Synthesis of protein array using an anti-Her2 Fab with site-specific incorporation of pAcF. An excess of synthesized aminooxy-DNA compound (Scheme S1) is added to anti-Her2 pAcF Fab and incubated at 37 °C for 16 h. After purification, the anti-Her2-oligonucleotide conjugate is added to the array and annealed to its complementary strand. Her2 positive tumor cells can then be captured and analyzed.